A Patient with Sickle Cell Disease and Recurrent Venous Thromboembolism after Renal Transplantation

Venous thromboembolism (VTE) is a life-threatening complication, especially in case of recurrence. The appropriate duration anticoagulant treatment following the first event crucial. Risk factors that increase risk recurrence VTE are many, and include medications, kidney disease, renal transplantation (RT), diagnosis sickle cell disease (SCD). There currently no guidelines define therapy after patient with RT. We report recurring episodes RT SCD patient. Our suggests use long-term may be recommended patients VTE.